Medpace Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medpace Holdings, Inc. on June 4, 2026, covering events occurring on June 1, 2026. The filing addresses Item 5.02 regarding the appointment of a new executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and compensation arrangements rather than financial performance.
Material Changes
Effective June 1, 2026, the Company appointed Brad W. Hansman as Executive Vice President, Operations. In this capacity, Mr. Hansman will serve as the principal operating officer alongside Susan E. Burwig. Mr. Hansman has been with the Company since April 2011, previously holding roles in Finance & Accounting and various leadership positions in operations including study start-up, logistics, regulatory affairs, and medical writing.
Guidance, Outlook, and Compensation
In connection with his appointment, Mr. Hansman will receive an annual base salary of $492,250. He is eligible to participate in the Company's short-term incentive compensation plan and the long-term equity incentive plan, subject to the discretion of the Compensation Committee. The filing notes no material interest transactions or family relationships requiring disclosure under Item 404(a) of Regulation S-K. No forward-looking guidance or risk factors were disclosed in this specific filing.
Investor Verification Checklist
- Verify the effective date of Brad W. Hansman's appointment as Executive Vice President, Operations (June 1, 2026).
- Confirm the annual base salary of $492,250 and eligibility for short-term and long-term incentive plans.
- Review the Company's Proxy Statement filed on April 1, 2026, for details on the short-term incentive compensation plan structure.
- Confirm that Mr. Hansman shares the principal operating officer role with Susan E. Burwig.